Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time

Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time

Bibliographic Details
Main Author:	The Staff
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791458/?tool=EBI

Similar Items

Correction: Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
by: PLOS ONE Staff
Published: (2022-01-01)

Healthy volunteers in US phase I clinical trials: Sociodemographic characteristics and participation over time.
by: Corey A Kalbaugh, et al.
Published: (2021-01-01)

Sociodemographic characteristics of healthy volunteers along with their experience, attitude and concerns of clinical trials in Wuhan, China
by: Hengyi Yu, et al.
Published: (2023-11-01)

Awareness of Clinical Trials Participation among Healthy Volunteers
by: Yusof, Yuhanif, et al.
Published: (2020)

Participation of Healthy Volunteers in Clinical Trials - Motives, Barriers, and Ethical Issues
by: Raja Sajjad Asghar, et al.
Published: (2023-03-01)

MOTIVATION AND PARTICIPATION EXPERIENCE OF HEALTHY VOLUNTEERS IN THE CLINICAL TRIALS OF BIOEQUIVALENCE IN RUSSIA
by: I. V. Mareev, et al.
Published: (2019-01-01)

Healthy volunteers' perceptions of risk in US Phase I clinical trials: A mixed-methods study.
by: Jill A Fisher, et al.
Published: (2018-11-01)

The problem of over-volunteering in early phase clinical trials
by: S. B. Fitilev, et al.
Published: (2018-07-01)

Sociodemographic and psychological characteristics influencing patients’ willingness to participate in clinical trials
by: Vitor Tedim Cruz, et al.
Published: (2022-10-01)

Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
by: Igor Radanovic, et al.
Published: (2022-08-01)

A phase I trial of Gynostemma pentaphyllum Makino in healthy volunteers
by: Malee Banjob, et al.
Published: (2007-03-01)

Pharmacokinetic Characteristics of Siponimod in Healthy Volunteers and Patients With Multiple Sclerosis: Analyses of Published Clinical Trials
by: Chen Chaoyang, et al.
Published: (2022-05-01)

The Effects of Moxifloxacin and Gemifloxacin on the ECG Morphology in Healthy Volunteers: A Phase 1 Randomized Clinical Trial
by: Abid Ullah, et al.
Published: (2023-03-01)

Methodical principles of assessment of financial compensation for clinical trial volunteer participants
by: V. Ye. Dobrova
Published: (2013-10-01)

Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
by: Borna A Nyaoke, et al.
Published: (2017-01-01)

Reasons for participating in a randomised clinical trial: The volunteers' voices in the COSTOP trial in Uganda
by: Agnes Ssali, et al.
Published: (2017-09-01)

Factors Influencing Participation Of Healthy Volunteers In Clinical Trials: Findings From A Cross-Sectional Study In Delhi, North India
by: Ranjan R, et al.
Published: (2019-11-01)

Comparative analysis of diets in Sioux Falls: Influence of sociodemographic characteristics, alignment to US national diet and healthy diet
by: Jacinda Netzer, et al.
Published: (2024-04-01)

Sociodemographic and Clinical Characteristics Associated with Improvements in Quality of Life for Participants with Opioid Use Disorder
by: Assaf Gottlieb, et al.
Published: (2022-01-01)

Comparing the sociodemographic characteristics of participants and non-participants in the population-based Tromsø Study
by: Chi Quynh Vo, et al.
Published: (2023-05-01)

Specifics of motivation of volunteers participating in in a clinical trial of the COVID-19 vaccine
by: Y. D. Belousova, et al.
Published: (2023-03-01)

44 Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya
by: B.A. Nyaoke, et al.
Published: (2016-07-01)

Characterization of renal biomarkers for use in clinical trials: biomarker evaluation in healthy volunteers
by: Brott DA, et al.
Published: (2014-02-01)

The role of reference intervals of laboratory tests in early phase clinical research in healthy volunteers
by: A. V. Vozzhaev, et al.
Published: (2018-07-01)

Sociodemographic disparities in ophthalmological clinical trials
by: Leo Anthony Celi, et al.
Published: (2023-12-01)

Sociodemographic disparities in ophthalmological clinical trials
by: Nakayama, Luis Filipe, et al.
Published: (2023)

A phase I single-blind clinical trial to evaluate the safety of oil palm phenolics (OPP) supplementation in healthy volunteers
by: Syed Fairus, et al.
Published: (2018-05-01)

Clinical, ethical and financial implications of incidental imaging findings: experience from a phase I trial in healthy elderly volunteers.
by: David J Pinato, et al.
Published: (2012-01-01)

Volunteer Participation in the Health eHeart Study: A Comparison with the US Population
by: Xiaofan Guo, et al.
Published: (2017-05-01)

Time- and Race-Specific Haematological Reference Intervals for Healthy Volunteer Trials: A Retrospective Analysis of Pooled Data From Multiple Phase I Trials
by: Simon Coates, et al.
Published: (2020-03-01)

Buccal acetaminophen provides fast analgesia: two randomized clinical trials in healthy volunteers
by: Pickering G, et al.
Published: (2014-09-01)

Acute outcomes of acupuncture and dry needling over peripheral acute fatigue in untrained healthy volunteers: A randomized controlled clinical trial
by: Gabriel Antonino, et al.
Published: (2023-09-01)

Sociodemographic characteristics and correlates of Delta-8 THC use in US adults
by: O. Livne
Published: (2022-06-01)

Sociodemographic characteristics of patients and their use of post-bariatric contouring surgery in the US
by: Ibrahim Al-Sumaih, et al.
Published: (2022-03-01)

A phase 1 clinical trial of SP16, a first-in-class anti-inflammatory LRP1 agonist, in healthy volunteers.
by: George F Wohlford, et al.
Published: (2021-01-01)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
by: Seyed Ebrahim ESKANDARI, et al.
Published: (2019-06-01)

First clinical trials of the inhaled epithelial sodium channel inhibitor BI 1265162 in healthy volunteers
by: Alison Mackie, et al.
Published: (2021-02-01)

First-in-human phase I clinical trial of a TLR4-binding DNA aptamer, ApTOLL: Safety and pharmacokinetics in healthy volunteers
by: Macarena Hernández-Jiménez, et al.
Published: (2022-06-01)

Comparison of sociodemographic and health-related characteristics of UK Biobank participants with the general population
by: Fry, A, et al.
Published: (2017)

Correction to: Chikungunya outbreak in Bangladesh (2017): sociodemographic and clinical characteristics of patients from three hotspots
by: Mohammad Robed Amin, et al.
Published: (2022-01-01)